Home LiteratureArticle Details
PMID: 1870196 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells.

Journal of virology ·Vol. 65 ·No. 9 ·1991-09-00 ·Pages 4691-8

Grez M, Zörnig M, Nowock J, Ziegler M

Abstract

The expression of Moloney murine leukemia virus (Mo-MuLV) and Mo-MuLV-derived vectors is restricted in undifferentiated mouse embryonal carcinoma and embryonal stem (ES) cells. We have previously described the isolation of retroviral mutants with host range properties expanded to embryonal cell lines. One of these mutants, the murine embryonic stem cell virus (MESV), is expressed in ES cell lines. Expression of MESV in these cells relies on DNA sequence motifs within the enhancer region of the viral long terminal repeat (LTR). Here we show that replacement of the Mo-MuLV enhancer region by sequences derived from the MESV LTR results in the activation of the Mo-MuLV LTR in ES cells. The enhancer regions of MESV and Mo-MuLV differ by seven point mutations. Of these, a single point mutation at position -166 is sufficient to activate the Mo-MuLV LTR and to confer enhancer-dependent expression to Mo-MuLV-derived retroviral vectors in ES cells. This point mutation creates a recognition site for a sequence-specific DNA-binding factor present in nuclear extracts of ES cells. This factor was found by functional assays to be the murine equivalent to human Sp1.

MeSH Terms
Base Sequence Cell Line Cloning, Molecular DNA, Viral/genetics DNA-Binding Proteins/genetics Enhancer Elements, Genetic Gene Expression Regulation, Viral Molecular Sequence Data Moloney murine leukemia virus/genetics Mutation Promoter Regions, Genetic Repetitive Sequences, Nucleic Acid Stem Cells/microbiology Transcription, Genetic
Chemicals
DNA, Viral DNA-Binding Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Grez M
Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Universität Hamburg, Germany.
Zörnig M
Nowock J
Ziegler M
References (34)
34 references, click to expand
  1. Mechanism of suppression of the long terminal repeat of Moloney leukemia virus in mouse embryonal carcinoma cells.
    Mol Cell Biol. 1989 Nov;9(11):4670-6 PMID: 2601693
  2. Negative regulation of retrovirus expression in embryonal carcinoma cells mediated by an intragenic domain.
    J Virol. 1988 Nov;62(11):4086-95 PMID: 3172339
  3. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements.
    Nucleic Acids Res. 1987 Jul 10;15(13):5490 PMID: 3037497
  4. Negative regulation of viral enhancers in undifferentiated embryonic stem cells.
    Cell. 1985 Sep;42(2):519-26 PMID: 2992802
  5. A safe packaging line for gene transfer: separating viral genes on two different plasmids.
    J Virol. 1988 Apr;62(4):1120-4 PMID: 2831375
  6. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells.
    Cell. 1987 Nov 6;51(3):503-12 PMID: 2822260
  7. Retroviral mutants efficiently expressed in embryonal carcinoma cells.
    Proc Natl Acad Sci U S A. 1986 May;83(10):3292-6 PMID: 3010288
  8. Viral transfer, transcription, and rescue of a selectable myeloproliferative sarcoma virus in embryonal cell lines: expression of the mos oncogene.
    Mol Cell Biol. 1986 Jan;6(1):286-93 PMID: 3023829
  9. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.
    Science. 1986 May 9;232(4751):755-9 PMID: 3008338
  10. Interaction of the TGGCA-binding protein with upstream sequences is required for efficient transcription of mouse mammary tumor virus.
    EMBO J. 1987 May;6(5):1355-60 PMID: 3038519
  11. Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells.
    Proc Natl Acad Sci U S A. 1987 Aug;84(15):5232-6 PMID: 3037539
  12. A beta-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies.
    Proc Natl Acad Sci U S A. 1987 Oct;84(19):6795-9 PMID: 3116543
  13. Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses.
    Genes Dev. 1988 Mar;2(3):267-81 PMID: 3288540
  14. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA.
    J Virol. 1986 Jan;57(1):37-45 PMID: 2416955
  15. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus.
    J Virol. 1989 Oct;63(10):4210-23 PMID: 2778872
  16. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells.
    Nature. 1989 Jun 8;339(6224):446-51 PMID: 2725678
  17. Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.
    J Virol. 1989 May;63(5):2317-24 PMID: 2704078
  18. Transcriptional selectivity of viral genes in mammalian cells.
    Cell. 1986 Sep 12;46(6):795-805 PMID: 3530495
  19. Proviral sequences that restrict retroviral expression in mouse embryonal carcinoma cells.
    Mol Cell Biol. 1987 Oct;7(10):3775-84 PMID: 3683398
  20. Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells.
    J Virol. 1987 Sep;61(9):2742-6 PMID: 3612950
  21. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer.
    Mol Cell Biol. 1987 Mar;7(3):1101-10 PMID: 3561410
  22. Tissue-specific in vitro transcription from the mouse albumin promoter.
    Cell. 1986 Dec 5;47(5):767-76 PMID: 3779841
  23. Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells.
    Cell. 1986 Nov 7;47(3):391-9 PMID: 3768959
  24. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector.
    Nature. 1986 Oct 2-8;323(6087):445-8 PMID: 3762693
  25. Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design.
    J Virol. 1990 Feb;64(2):534-42 PMID: 2153223
  26. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.
    Genes Dev. 1990 Feb;4(2):233-42 PMID: 2338244
  27. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
    Mol Cell Biol. 1982 Sep;2(9):1044-51 PMID: 6960240
  28. Non-function of a Moloney murine leukaemia virus regulatory sequence in F9 embryonal carcinoma cells.
    Nature. 1984 Mar 29-Apr 4;308(5958):470-2 PMID: 6323996
  29. Nucleotide sequence of Moloney murine leukaemia virus.
    Nature. 1981 Oct 15-21;293(5833):543-8 PMID: 6169994
  30. Silent infection of murine embryonal carcinoma cells by Moloney murine leukemia virus.
    Virology. 1980 Aug;105(1):241-4 PMID: 7414951
  31. Virus infection of murine teratocarcinoma stem cell lines.
    Cell. 1977 Dec;12(4):973-82 PMID: 202395
  32. Determinants of retrovirus gene expression in embryonal carcinoma cells.
    J Virol. 1991 Jan;65(1):382-8 PMID: 1845898
  33. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells.
    Proc Natl Acad Sci U S A. 1990 Dec;87(23):9202-6 PMID: 2251265
  34. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif.
    Cell. 1988 Dec 2;55(5):887-98 PMID: 3142690
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1991-09-00
Pages
4691-8
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC248924
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com